InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: jessellivermore post# 4929

Wednesday, 04/24/2013 9:05:04 AM

Wednesday, April 24, 2013 9:05:04 AM

Post# of 425931
If amarin needs cash down the road it can pull a few levers :

1) sell worldwide rights of Vascepa ex-US, ex-Japan (probably worth the current market cap)
2) license Vascepa to Pfizer, AZN, Merck, Lily, etc for combo (each company pay just $250MM and you get the current market cap)
3) sell the company @ $15/sh if the Vascepa launch do not live up to expectation, ala HGSI.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News